Why AeroVironment Stock Rocketed Higher Today

AeroVironment's fiscal Q1 2027 revenue reached a record $480.5 million, up 6% year over year and above the $456.1 million consensus, while adjusted EPS surged 84% to $0.59 versus the $0.25 expected. Bookings rose 71% to $683 million, producing a 1.4 book-to-bill ratio, and funded backlog increased 37% year over year to a record $1.5 billion. Management maintained full-year revenue guidance of roughly $2.175 billion (+10%) and adjusted EPS guidance of $3.16 (-4%), with planned expansion and depreciation weighing on profit; shares rose as much as 13% intraday.

Analysis

The earnings surprise matters less for the quarter than for whether the company can convert defense demand into profitable throughput. The mix shift toward autonomous systems should support revenue durability, but the unchanged full-year profit outlook implies incremental volume is presently being absorbed by integration, facility ramp, depreciation, and likely lower initial program margins. That makes the next two reports a test of gross-margin progression and operating-cash conversion rather than another headline beat.

The key second-order beneficiary is AVAV's positioning as a prime integrator across small UAS, counter-UAS, loitering munitions, and newer space/cyber capabilities; this can consolidate wallet share that might otherwise flow to Kratos (KTOS), Red Cat (RCAT), Teledyne (TDY), and defense-electronics suppliers. Conversely, a prolonged U.S. continuing resolution or a shift in DoD procurement toward lower-cost, attritable platforms could delay awards and turn unfunded opportunities into a valuation trap. The prior accounting issue and contract loss mean the market will likely require two clean quarters before assigning a sustained multiple re-rating.

Consensus may be over-crediting the apparent valuation reset: a forward earnings multiple near 48x still requires high-teens-to-20% medium-term EPS growth, while current guidance points to near-term earnings dilution. The stock can work tactically on backlog conversion, but the 6-18 month upside depends on capacity investment generating operating leverage; if margins do not inflect by the second half of the fiscal year, the multiple remains vulnerable even with solid top-line growth.

Key Decisions for Investors

• Tactical long AVAV only after the post-earnings move holds for 3-5 trading sessions and management provides evidence of funded-backlog conversion; target a 10-15% move over 1-3 months, with a 7-8% stop below the post-results support level.
• Do not underwrite a 6-18 month core position until the next two earnings reports show expanding consolidated gross margin and operating cash flow tracking earnings; a repeat of strong bookings without margin improvement falsifies the capacity-leverage thesis.
• For relative-value exposure, consider long AVAV / short KTOS in equal dollar amounts over 3-6 months if AVAV's autonomous-systems growth remains above 15% while KTOS award cadence slows. Exit if AVAV's funded backlog declines sequentially or KTOS secures a major production-scale counter-UAS award.
• Monitor federal appropriations and continuing-resolution risk through the next budget milestones. A procurement delay, adverse accounting remediation disclosure, or reduction in full-year profit guidance should trigger an immediate reduction in AVAV exposure rather than averaging down.